These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 5150164)

  • 1. Serotonin accumulation after monoamine oxidase inhibition. Effects of decreased impulse flow and of some anti-depressants and hallucinogens.
    Meek JL; Fuxe K
    Biochem Pharmacol; 1971 Mar; 20(3):693-706. PubMed ID: 5150164
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of acute axotomy (spinal cord transection) on the turnover of 5-hydroxytryptamine.
    Andén NE
    Adv Biochem Psychopharmacol; 1974; 10():35-43. PubMed ID: 4276958
    [No Abstract]   [Full Text] [Related]  

  • 3. Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons.
    Andén NE; Corrodi H; Fuxe K
    J Pharmacol Exp Ther; 1971 Nov; 179(2):236-49. PubMed ID: 5133600
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic studies on the structure-activity relationship of hydroxyindole alkylamines.
    Cerletti A; Taeschler M; Weidmann H
    Adv Pharmacol (1962); 1968; 6(Pt B):233-46. PubMed ID: 5658327
    [No Abstract]   [Full Text] [Related]  

  • 5. The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Mt Sinai J Med; 1974; 41(2):276-82. PubMed ID: 4544624
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of hallucinogens and psycholeptic drugs on blood pressure reflexes and behavioral reactions in nonanesthetized cats.
    Balint GA
    Isr J Med Sci; 1972 Apr; 8(4):556-8. PubMed ID: 5034804
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of quipazine on the turnover rate of serotonin.
    Grabowska M; Antkiewicz L; Michaluk J
    Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons.
    Lidbrink P; Jonsson G; Fuxe K
    Neuropharmacology; 1971 Sep; 10(5):521-36. PubMed ID: 4399540
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants.
    Lucki I; Frazer A
    Psychopharmacology (Berl); 1982; 77(3):205-11. PubMed ID: 6812141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropharmacologic similarities and differences between the hallucinogens and the antidepressants].
    Thuillier J; Nakajima H
    Arzneimittelforschung; 1966 Feb; 16(2):222-6. PubMed ID: 6014084
    [No Abstract]   [Full Text] [Related]  

  • 12. Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4).
    Jain M; Bakutis E; Gayle T; Lansky P
    Neurobiology; 1974; 4(3):180-90. PubMed ID: 4367441
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical-feedback regulation of serotonin-containing neurons in brain.
    Aghajanian GK
    Ann N Y Acad Sci; 1972 Aug; 193():86-94. PubMed ID: 4262796
    [No Abstract]   [Full Text] [Related]  

  • 14. Spinal monoamines and the toxic interaction between monoamine oxidase inhibitors and tricyclic antidepressants.
    Clineschmidt BV
    Eur J Pharmacol; 1972 Jul; 19(1):126-9. PubMed ID: 4403107
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of drugs on serotonergic nerve terminals.
    Bloom FE; Costa E
    Adv Cytopharmacol; 1971 May; 1():379-95. PubMed ID: 5163249
    [No Abstract]   [Full Text] [Related]  

  • 16. The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.
    Martin WR; Eades CG
    Psychopharmacologia; 1970; 17(3):242-57. PubMed ID: 5310035
    [No Abstract]   [Full Text] [Related]  

  • 17. Hallucinogenic phenylethylamines: interactions with serotonin turnover and receptors.
    Andén NE; Corrodi H; Fuxe K; Meek JL
    Eur J Pharmacol; 1974 Feb; 25(2):176-84. PubMed ID: 4435021
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of phenylethylamine metabolism in vivo-Effect of antidepressants.
    Von Voigtlander PF; Losey EG
    Biochem Pharmacol; 1976 Jan; 25(2):217-8. PubMed ID: 1259787
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles.
    Marchbanks RM
    Biochem Pharmacol; 1967 Oct; 16(10):1971-9. PubMed ID: 6065963
    [No Abstract]   [Full Text] [Related]  

  • 20. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo.
    Gorkin VZ; Romanova LA
    Biochem Pharmacol; 1968 Jun; 17(6):855-60. PubMed ID: 5661349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.